Bone Modifying Agents

We are starting a supportive care series, because these topics comes up very often in oncology. This week's episode will be focusing on Bone Modifying Agents, such as bisphosphonates and Denosumab - when they are indicated, mechanism of action, and key pearls/toxicities.